This is not a Hail Mary last ditch. They have many

This is not a Hail Mary last ditch. They have many possible sources of funding from now to milestone payments from the HIV deal. This is just a “thanks for hanging in there” opportunity offered by the company to long term investors. Don’t read too much beyond this. There are many advanced talks going on and this drug is very valuable. The big investment has been and is being made with direct placement funds, not from open market buying. The otc is only to allow warrant holders to sell some shares as a risk management tactic and for us non-accredited investors to pick up cheap shares. The stock price has little to do with the value of this drug. It is unfortunate that fund raising has been done at this low levels but this is transitioning away from that. I know this because I asked the company and discussed in length. They do not need the funds from this offer, it is for investors interested in a larger position and the company is giving the opportunity that the Paulson investors have had as a merely a perk. This is the last chance to get a deal like this. Things are changing for the good very soon.